MIT has launched an as-yet unnamed spinout to develop a smart drug-delivery pill to help plan more effective treatment regimens for patients.

Massachusetts Institute of Technology (MIT) has launched an as-yet unnamed US-based spinout to commercialise a 3D-printable drug-delivery pill that would enable doctors to more effectively administer medication dosages, R&D Magazine has reported.
The ingestible technology would remain in the patient’s stomach for almost a month, relying on its built-in sensors and wireless Bluetooth transmitters to help professionals judge when medication should be dispersed.
MIT hopes the pill will prevent patients with diseases including HIV and malaria from prematurely…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?